SA
CAH icon

Shilanski & Associates’s Cardinal Health CAH Stock Holding History

Shilanski & Associates’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.13M Buy
+13,555
New +$2.09M 0.57% 50

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Shilanski & Associates's CAH Position: Q3 2025 in Review

Shilanski & Associates opened a new position in Cardinal Health (CAH) in Q3 2025: 13,555 shares worth $2.13M. The stake represents 0.57% of the portfolio and ranks #50 among its holdings.

1,225 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

  • Shilanski & Associates held 13,555 shares of Cardinal Health worth $2.13M as of Q3 2025.
  • Cardinal Health was a new Shilanski & Associates position in Q3 2025.
  • Cardinal Health made up 0.57% of Shilanski & Associates's portfolio in Q3 2025, its #50 holding.
  • 1,225 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on Shilanski & Associates's 13F filing for Q3 2025, filed 20 Oct 2025.